RACE ONCOLOGY LTD

5.28%

$1.17

Market Cap $202.3M

Healthcare Biotechnology

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight

WEBINAR REPLAY: RACE ONCOLOGY

Latest Threads

Tag

Subject

RAC

RAC media coverage

39 40 41

05:05

2.4K

866K

05:05

Last post PlayMoney76

2.4K

866K

RAC

Ann: Race Investor Presentation

2 3

05:03

145

33K

05:03

Last post PlayMoney76

145

33K

RAC Biotech

RAC - Charts & Price Action

412 413 414

04:49

24K

8.9M

04:49

Last post PlayMoney76

24K

8.9M

RAC

Cardioprotection thread

17 18 19

21/03/25

1.1K

364K

21/03/25

Last post

RaceOncology

1.1K

364K

RAC

General Comments / Chat

212 213 214

21/03/25

12K

4.6M

21/03/25

Last post Burge13

12K

4.6M

RAC

RAC - Crystal ball gazing

2 3

19/03/25

139

38K

19/03/25

Last post PlayMoney76

139

38K

RAC

Industry news

48 49 50

19/03/25

2.9K

986K

19/03/25

Last post

RaceOncology

2.9K

986K

RAC

Ann: Race Online Investor Briefing Invitation

18/03/25

6.7K

18/03/25

Last post IndexInvestor

6.7K

RAC

Ann: Ethics approval received for RC220 Phase 1 Trial

17/03/25

24K

17/03/25

Last post Guemar

24K

RAC

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma

16/03/25

36K

16/03/25

Last post Mason14

36K

RAC

Ann: Race Submits Human Ethics for RC220 Phase 1 Trial

15 16 17

14/03/25

997

287K

14/03/25

Last post ktrobins

997

287K

RAC

Pillar 1 - FTO (new thread)

50 51 52

13/03/25

3.0K

1.1M

13/03/25

Last post couldwellb

3.0K

1.1M

RAC

Accent Therapeutics: What can we learn?

12/03/25

11K

12/03/25

Last post The Knightrider

11K

RAC

Ann: Race releases complete cardio-protection data & video

4 5 6

11/03/25

318

117K

11/03/25

Last post Mason14

318

117K

RAC

Ann: Race Signs Contract for Phase 1 Trial of RC220

10/03/25

24K

10/03/25

Last post DDD24

24K

RAC

Ann: S&P DJI Announces March 2025 Quarterly Rebalance

10/03/25

3.6K

10/03/25

Last post johndprent

3.6K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Race Investor Presentation
17 Mar 16:53	Share

Race Online Investor Briefing Invitation
14 Mar 11:08	Share

Ethics approval received for RC220 Phase 1 Trial
14 Mar 08:47	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Race Signs Contract for Phase 1 Trial of RC220
05 Mar 08:58	Share

Appendix 4D & Half-Year Financial Statements
25 Feb 13:42	Share

Application for quotation of securities - RAC
04 Feb 13:06	Share

Quarterly Activity Report and Appendix 4C
31 Jan 08:57	Share

Application for quotation of securities - RAC
16 Jan 15:57	Share

Appendix 3X - Dr Megan Baldwin
02 Jan 08:22	Share

Race Strengthens Board
18 Dec 08:53	Share

Race Receives $5.25m RD Tax Refund for Financial Year 2024
17 Dec 10:26	Share

Race Submits Human Ethics for RC220 Phase 1 Trial
05 Dec 08:44	Share

Race 2024 Annual General Meeting Video Release
28 Nov 14:44	Share

Appendix 3Y - Dr Serge Scrofani
26 Nov 17:40	Share

Notification regarding unquoted securities - RAC
26 Nov 17:28	Share

Results of Annual General Meeting
25 Nov 13:41	Share

Race Oncology 2024 Chairs Address and AGM Presentation
25 Nov 09:28	Share

Application for quotation of securities - RAC
22 Nov 14:53	Share

Race Discovers Multiple Novel FTO Inhibitor Candidates
21 Nov 09:25	Share

Notification regarding unquoted securities - RAC
07 Nov 15:41	Share

Annual Report to Shareholders
23 Oct 12:28	Share

Letter to Shareholders, Notice of AGM & Proxy Form
23 Oct 12:27	Share

Quarterly Activity Report and Appendix 4C
21 Oct 10:27	Share

Application for quotation of securities - RAC
17 Oct 13:37	Share

Date of AGM & Closing Date for Director Nominations
07 Oct 08:59	Share

Application for quotation of securities - RAC
03 Oct 13:20	Share

Notification of cessation of securities - RAC
02 Oct 08:24	Share

Application for quotation of securities - RAC
26 Sep 11:07	Share

E&P Conference Presentation
26 Sep 11:07	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.17		Change -0.065(5.28%)		Mkt cap ! $202.3M

Open	High	Low	Value	Volume
$1.23	$1.23	$1.17	$95.81K	81.1K

Buyers (Bids)

No.	Vol.	Price($)
1	2145	$1.17

Sellers (Offers)

Price($)	Vol.	No.
$1.19	4000	1

View Market Depth

No.	Vol.	Price($)
1	2145	1.165
1	2280	1.160
1	864	1.155
2	16793	1.150
1	2500	1.140

Price($)	Vol.	No.
1.185	4000	1
1.190	2096	1
1.200	1929	1
1.220	9000	1
1.235	3663	1

Last trade - 16.10pm 21/03/2025 (20 minute delay)

RAC (ASX) Chart

RACE ONCOLOGY LTD

Corporate Spotlight

Latest Threads

Corporate Spotlight

Timeline

Featured News

Latest Videos

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

14 May 2024 09:56 (AEST)

Race Oncology (ASX:RAC) strikes contracts to start observational breast cancer trial

13 Mar 2023 15:00 (AEDT)

Race Oncology (ASX:RAC) enters new collaboration investigating heart protection during chemo

02 Mar 2023 15:49 (AEDT)

Latest Articles

Race Oncology approved for Phase I trial for chemotherapeutic treatments

Race Oncology Ltd has received approval to go ahead with its Phase I trial to assess R220 and begin enrolling patients

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University in Melbourne

Race delivers promising results in cancer drug mice research into heart complications

Race Oncology (ASX:RAC) has announced a preclinical breakthrough in heart toxicity side effects caused by the carfilzomib, which had precluded the drug being administered to patients diagnosed with elevated cardiac risk factors.In work performed under contract by Labcorp in the United States, Rac...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News